Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

An unexpected increase of troponin I after perphenazine depot injection.

Baffoni L, Pedrazzi R, Neri R, Marzaloni M.

Ann Pharmacother. 2004 Feb;38(2):353-4. No abstract available.

PMID:
14742781
2.

Neuroleptics, extrapyramidal symptoms, and serum-calcium levels.

el-Defrawi MH, Craig TJ.

Compr Psychiatry. 1984 Nov-Dec;25(6):539-45. No abstract available.

PMID:
6150808
3.

[Correction of an extrapyramidal neuroleptic syndrome with tryptophan and the dynamics of its concentration in the blood of patients].

Balakleevskiĭ AI, Mitiukova TA, Vazhenin MM, Gaĭduk FM.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1981;81(2):95-7. Russian. No abstract available.

PMID:
6112836
4.

Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline.

Gourzis P, Polychronopoulos P, Argyriou AA, Bakalidou C, Beratis S.

Clin Neuropharmacol. 2004 Nov-Dec;27(6):299-300.

PMID:
15613935
5.

Tetany, tetanus or drug reaction? A case report.

Smith WD, Tobias MA.

Br J Anaesth. 1976 Jul;48(7):703-5.

PMID:
1016648
6.

Idiosyncratic responses to phenothiazines.

Ramsden PD, Froggatt DL.

Br Med J. 1972 Jan 22;1(5794):246. No abstract available.

7.

Acute dystonia induced by the combination of midodrine and perphenazine.

Castrioto A, Tambasco N, Rossi A, Calabresi P.

J Neurol. 2008 May;255(5):767-8. doi: 10.1007/s00415-008-0805-y. No abstract available.

PMID:
18344053
8.
9.

Further information available on extrapyramidal symptoms.

Skewes A.

Nurse Pract. 1993 Feb;18(2):13. No abstract available.

PMID:
8096070
10.

Predictors for starting depot administration of risperidone in chronic users of antipsychotics.

Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.

J Clin Psychopharmacol. 2008 Dec;28(6):625-30. doi: 10.1097/JCP.0b013e31818a6d10.

PMID:
19011430
11.

[Antipsychotic agents and pregnancy].

Damkier P.

Ugeskr Laeger. 2007 Aug 13;169(33):2659; author reply 2659. Danish. No abstract available.

PMID:
17763573
12.

Neuroleptic malignant syndrome: a review.

Dallman JH.

Mil Med. 1984 Aug;149(8):471-3. No abstract available.

PMID:
6147794
13.

Neuroleptic malignant syndrome.

Cummins P.

Br J Psychiatry. 1984 May;144:556. No abstract available.

PMID:
6145478
14.

[Extrapyramidal symptoms induced by anti-psychotic drugs].

Horiguchi J.

Seishin Shinkeigaku Zasshi. 2001;103(7):546-55. Review. Japanese. No abstract available.

PMID:
11708250
15.

Ziprasidone-induced acute dystonia.

Mason MN, Johnson CE, Piasecki M.

Am J Psychiatry. 2005 Mar;162(3):625-6. No abstract available.

PMID:
15741487
16.

Extrapyramidal syndrome associated with pipothiazines.

Schiff AA.

J Clin Psychiatry. 1984 Mar;45(3):145. No abstract available.

PMID:
6142038
17.

[The malignant neuroleptic syndrome].

Hilpert F, Cohen A, Auzépy P.

Rev Prat. 1984 Mar 1;34(13):633-9. French. No abstract available.

PMID:
6143390
18.

Nursing and extrapyramidal symptoms: a response to Clarke.

Mutsatsa S, Rinomhota S.

J Psychiatr Ment Health Nurs. 2002 Apr;9(2):221-5. No abstract available.

PMID:
11966993
19.

Implications of the CATIE trial on treatment: extrapyramidal symptoms.

Casey DE.

CNS Spectr. 2006 Jul;11(7 Suppl 7):25-31.

PMID:
16816797
20.

Cannabis-induced extrapyramidalism in a patient on neuroleptic treatment.

Rejón Altable C, Rodríguez Urrutia A, Carrión Martínez MI.

J Clin Psychopharmacol. 2005 Feb;25(1):91-2. No abstract available.

PMID:
15643106
Items per page

Supplemental Content

Support Center